Cargando…
A case report of steroid-refractory bullous pemphigoid induced by immune checkpoint inhibitor therapy
The widespread use of immune checkpoint inhibitors in several malignancies has revealed new immune-related adverse events. Bullous pemphigoid (BP) is an antibody-driven autoimmune disease characterized by skin inflammation and fluid-filled bullae. Herein, a 69-year-old man with lung squamous cell ca...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845947/ https://www.ncbi.nlm.nih.gov/pubmed/36685586 http://dx.doi.org/10.3389/fimmu.2022.1068978 |